Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03821155
Other study ID # 2018-166
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2019
Est. completion date January 1, 2022

Study information

Verified date July 2022
Source Aalborg University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate which treatment option (corticosteroid treatment alone or combined corticosteroid treatment and vestibular rehabilitation) is the most effective in patients diagnosed with vestibular neuritis.


Description:

Patients diagnosed with vestibular neuritis will we consider for enrollment. Each patient will undergo randomization for a specific treatment.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 1, 2022
Est. primary completion date July 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age above 18 years of age 2. Medical history compatible with vestibular neuritis 3. Verification of vestibular neuritis with positive romberg test, pathological v-HIT and horizontal nystagmus with a rotatory component. Exclusion Criteria: 1. Former medical history with vestibular dysfunction 2. Medical history or objective signs of cochlear dysfunction before, during or after onset of vestibular neuritis 3. Onset of symptoms 14 days before recruitment to the study 4. Focal neurological symptoms/signs 5. Contraindication to prednisolone treatment 6. Problem with participating in vestibular rehabilitation due to muscular-skeletal disease ect.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Vestibular rehabilitation
Specialized physical therapy aimed at restoring balance
Drug:
Corticosteroid
Prednisolone

Locations

Country Name City State
Denmark Department of Otolaryngology, Head & Neck Surgery and Audiology Aalborg North Denmark Region

Sponsors (1)

Lead Sponsor Collaborator
Aalborg University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Suppressing head impulse paradigm (SHIMP) SHIMP equipment will objectively quantify change of vestibular function. 6 month
Primary Subjective visual vertical (SVV) SVV test will objectively quantify the experienced spatial orientation as an indicator of visual and vestibular otolithic function 6 month
Primary Video head impulse test (v-HIT) v-HIT equipment will objectively quantify change of vestibular function. 6 month
Primary Dizziness handicap inventory (DHI) questionnaire Fulfillment of the questionnaire "Dizziness Handicap Inventory" (DHI) will quantify the level of experienced vertigo. 6 month
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02655575 - Assessment and Treatment of Patients With Long-term Dizziness in Primary Care N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Completed NCT02098330 - The Efficacy of Steroid Therapy in Vestibular Neuritis Phase 3
Recruiting NCT04678167 - Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis N/A
Not yet recruiting NCT05424302 - Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy N/A
Recruiting NCT01231009 - The Role of Corticosteroids and Vestibular Exercises in Recovery of Vestibular Neuritis Phase 0
Completed NCT03452410 - MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla
Recruiting NCT04926363 - Prevalence of Cardiovascular Risk Factors in Upper Vestibular Neuritis
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Completed NCT02171312 - Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool N/A